The FDA's databases counts all a few from the commonly prescribed ADHD stimulant medicines as in scarcity: methylphenidate, amphetamine blended salts and lisdexamfetamine."We haven't been able to acquire more than enough raw materials to commercialize the item at total industrial scale, and Now we have employed our total quota for calendar yr 2023,